AIDX vs ALMR

20/20 Biolabs, Inc. vs Alamar Biosciences, Inc. — Valuation Comparison 2026

AIDX

Medical Devices
20/20 Biolabs, Inc.
Quality
5.6
out of 10
Value Trap
Price
$0.87
Last close
Models
10/13
Active
VS

ALMR

Medical Devices
Alamar Biosciences, Inc.
Quality
1.7
out of 10
Value Trap
Price
$20.44
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType AIDX Fair ValueAIDX Upside ALMR Fair ValueALMR Upside
Bayesian DCF Intrinsic $0.40 -53.6% $5.41 -73.5%
Earnings Power Value Intrinsic $0.22 -86.1%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $1.01 +16.8% $22.30 +9.1%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for AIDX vs ALMR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

AIDX vs ALMR — Which Stock Is More Undervalued?

AIDX scores higher with a 5.6/10 quality rating vs ALMR's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing 20/20 Biolabs, Inc. (AIDX) and Alamar Biosciences, Inc. (ALMR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

AIDX currently trades at $0.87 with a QOC of 5.6/10, while ALMR trades at $20.44 with a QOC of 1.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).